Jakob Weglage

Clinician Scientist

Charité

The projects of

Jakob Weglage

B04

Exploiting

Targeting

Chronotherapy of metabolic dysfunction-associated steatotic liver disease (MASLD)

MASLD is prevalent and a major risk factor for cirrhosis and liver cancer. Exercise is effective but limited by compliance. This project investigates how exercise timing interacts with hepatocyte circadian clocks to affect metabolism and MASLD progression.

Chronotherapy of metabolic dysfunction-associated steatotic liver disease (MASLD)

MASLD is prevalent and a major risk factor for cirrhosis and liver cancer. Exercise is effective but limited by compliance. This project investigates how exercise timing interacts with hepatocyte circadian clocks to affect metabolism and MASLD progression.

The publications of

Jakob Weglage

No items found.